APOE and prostate cancer: In contrast, another study revealed that prostate cancer-derived APOE can bind with its receptor (trigger receptor expressed on myeloid cells 2 [TREM2]) on neutrophils and induce their senescence; moreover, APOE expression is associated with poor prognosis in prostate cancer patients [29], thus indicating its oncoprotein feature.